Education
About Us
Working with TipRanks
Follow Us
Lineage Cell Therapeutics, Inc. (LCTX)
XASE:LCTX
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 14.56M | $ 9.50M | $ 8.95M | $ 14.70M | $ 3.90M |
| Gross Profit | $ 13.71M | $ 9.16M | $ 8.27M | $ 13.97M | $ 2.47M |
| Operating Income | $ -21.78M | $ -21.48M | $ -24.73M | $ -22.52M | $ -49.21M |
| EBITDA | $ -21.08M | $ -20.87M | $ -24.04M | $ -21.79M | $ -48.34M |
| Net Income | $ -63.53M | $ -18.61M | $ -21.49M | $ -26.27M | $ -43.02M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 55.78M | $ 47.80M | $ 35.49M | $ 57.88M | $ 58.36M |
| Total Assets | $ 112.58M | $ 113.22M | $ 101.02M | $ 123.66M | $ 174.54M |
| Total Debt | $ 2.42M | $ 2.51M | $ 2.95M | $ 3.90M | $ 2.80M |
| Net Debt | $ -38.37M | $ -43.27M | $ -32.49M | $ -7.46M | $ -52.94M |
| Total Liabilities | $ 69.24M | $ 36.21M | $ 39.00M | $ 51.73M | $ 83.65M |
| Stockholders' Equity | $ 44.55M | $ 78.38M | $ 63.42M | $ 73.34M | $ 92.22M |
| Cash Flow | |||||
| Free Cash Flow | $ -19.44M | $ -23.66M | $ -29.24M | $ 646.00K | $ -23.91M |
| Operating Cash Flow | $ -18.92M | $ -23.09M | $ -28.57M | $ 1.06M | $ -23.56M |
| Investing Cash Flow | $ -13.46M | $ -2.31M | $ 46.45M | $ -46.16M | $ 9.74M |
| Financing Cash Flow | $ 26.95M | $ 35.86M | $ 6.42M | $ 1.63M | $ 36.93M |